Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer ...

UTEP researchers identify Claudin-4 protein as a target to improve immune response against aggressive ovarian cancer.

The late Dr. David Ahlquist co-invented ColoGuard, which is helping drive Abbott Laboratories’ acquisition of Exact Sciences. After an ALS diagnosis in 2019, Ahlquist wasn’t done inventing.

Most new cell therapies work well on blood cancers but not on solid tumors like pancreatic cancer. Pancreatic tumors are ...

Being overweight or obese is another important risk factor. When there is too much fat in the body, levels of certain ...

Jessie J—who spoke with Kate Middleton at the Royal Variety Performance—shared more details about their conversation ...

Zai Lab Limited today announced that the following medicines and indications have been renewed in the 2025 National Reimbursement Drug List (NRDL) released by China's National Healthcare Security ...

In what researchers are calling a ”breakthrough hiding in plain sight,” scientists have redesigned a 40-year-old deworming ...

Sonali Bendre’s post reflects a survivor who trusts modern medicine while exploring supportive wellness. Experts say these practices aid recovery, not cure cancer ...